Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler
The product will be manufactured at subsidiary Aurolife Pharma’s Raleigh facility in North Carolina and expected to be launched in upcoming quarters.
We haven't written up this one. The Hindu - Sci-Tech has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.